Oncopeptides AB (ONCO) — Cash Flow Reinvestment Rate
Latest as of June 2024:
0.00x
Oncopeptides AB (ONCO) has a Cash Flow Reinvestment Rate of 0.00x as of June 2024, reinvesting Skr0.00 (capex Skr0.00 ) from operating cash flow of Skr8.77 Million. See Oncopeptides AB (ONCO) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Reinvestment Rate
0.00x
(Capex + Investments) / Operating CF
Total Reinvested
Skr0.00
Capex + Investments
Operating Cash Flow
Skr8.77 Million
SEK
Capital Expenditures
Skr0.00
SEK
Annual Cash Flow Reinvestment Rate for Oncopeptides AB (None–None)
Year-by-year capital reinvestment analysis for Oncopeptides AB. See ONCO FCF to total liabilities ratio to measure the company's free cash flow as a share of total liabilities.
| Year | Reinvestment Rate | Total Reinvested (SEK) | Operating CF | Capex | YoY Change |
|---|
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow